A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

计划入组 400 人 · 首次发布于 2025 年 9 月 23 日

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

计划入组 270 人 · 首次发布于 2023 年 4 月 24 日

Relmacabtagene Autoleucel in Hematologic Malignancies

计划入组 150 人 · 首次发布于 2023 年 11 月 21 日

tacatresgene autoleucel

Actalycabtagene autoleucel

Brexucabtagene autoleucel(Tecartus)

St. David's South Austin Medical Center Enrolls First Patient Globally in Phase III CAR T-Cell Trial for Aggressive Large B-Cell Lymphoma

Lyell's Ronde-cel Shows 93% Response Rate in Large B-Cell Lymphoma with Enhanced Safety Profile

FDA Approves Obecabtagene Autoleucel for Relapsed/Refractory B-cell ALL